HKD 1.64
(1.86%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 20.2 Million USD | -39.77% |
2022 | 33.55 Million USD | 32.6% |
2021 | 25.3 Million USD | 61.43% |
2020 | 15.67 Million USD | 7.78% |
2019 | 14.54 Million USD | -0.14% |
2018 | 14.56 Million USD | -22.5% |
2017 | 18.79 Million USD | 66.88% |
2016 | 11.26 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 2.68 Million USD | 0.0% |
2023 Q4 | 11.7 Million USD | 0.0% |
2023 Q2 | 8.5 Million USD | 0.0% |
2023 FY | 20.2 Million USD | -39.77% |
2022 FY | 33.55 Million USD | 32.6% |
2022 Q2 | 17.23 Million USD | 0.0% |
2022 Q4 | 16.31 Million USD | 0.0% |
2021 Q2 | 11.64 Million USD | 0.0% |
2021 FY | 25.3 Million USD | 61.43% |
2021 Q4 | 13.66 Million USD | 0.0% |
2020 Q4 | 12.81 Million USD | 0.0% |
2020 Q2 | 2.86 Million USD | 0.0% |
2020 FY | 15.67 Million USD | 7.78% |
2019 Q4 | 4.13 Million USD | 0.0% |
2019 FY | 14.54 Million USD | -0.14% |
2019 Q2 | 10.4 Million USD | 0.0% |
2018 Q2 | 5.77 Million USD | 0.0% |
2018 Q4 | 12.87 Million USD | 0.0% |
2018 FY | 14.56 Million USD | -22.5% |
2017 Q1 | 4.11 Million USD | 0.0% |
2017 FY | 18.79 Million USD | 66.88% |
2017 Q4 | 3.61 Million USD | 0.0% |
2017 Q2 | 4.11 Million USD | 0.0% |
2016 Q4 | 4.11 Million USD | 0.0% |
2016 FY | 11.26 Million USD | 0.0% |
2016 Q1 | 2.51 Million USD | 0.0% |
2016 Q2 | 2.51 Million USD | 0.0% |
2015 Q4 | 2.51 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 67.76 Million HKD | 70.179% |
CK Life Sciences Int'l., (Holdings) Inc. | 897.95 Million HKD | 97.749% |